Delivery Order SPE2DB22D9112-SPE2DB25FTKQM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, will be performed in Park Ridge, Illinois, where the vendor is headquartered. The award does not utilize a set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status as a...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $30,820.14 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 ml auto-injector units. The contract was awarded on September 8, 2025, with an ultimate completion date of September 29, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order was issued without a...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,712.23 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 ml auto-injector units. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. The award was issued on August 25, 2025, with an ultimate completion date of September 16, 2025, and was not designated under any federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,712.23 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, issued on August 19, 2025, is scheduled for completion by September 10, 2025, with performance taking place in Park Ridge, Illinois. The contract utilizes no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, holds a...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Xolair 300 mg/2 mL auto-injector vials valued at $3,424.46. The award, issued on September 3, 2025, with a completion date of September 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group, based in Park Ridge, Illinois, will perform the delivery at its location. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $10,273.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, issued on September 9, 2025, carries an ultimate completion date of September 30, 2025, with no set-aside designation applied. The contract represents a discrete fulfillment under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order valued at $27,395.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injector medications. This firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of September 10, 2025, and does not utilize a set-aside designation. The award represents a specific fulfillment under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,136.69 to DMS Pharmaceutical Group Inc. on August 25, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a continuation of the agency's pharmaceutical supply chain operations. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injector units. This delivery order, issued on May 30, 2025, with a completion date of June 23, 2025, operates under a firm fixed-price structure with no set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc. for Xolair 300 mg/2 mL auto-injector syringes on August 19, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a specific pharmaceutical product requirement to be delivered to Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park...
- SPE2DB22D9112Indefinite Delivery Contract
- SPE2DB22D9112-SPE2DB25FTKQMDelivery Order
The Defense Logistics Agency awarded a $10,273.38 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of Xolair 300 mg/2 mL auto-injector vials. The contract carries an ultimate completion date of September 26, 2025, and involves delivery to Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, will fulfill this order without a set-aside designation, leveraging its established position within the federal pharmaceutical supply chain. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million through November 2026. The parent contract, administered through the SPE2DB program, enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has consistently demonstrated its capability as a critical supplier of specialty medications and auto-injectors to military health systems, with this Xolair delivery representing one of numerous pharmaceutical product fulfillments under the broader agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 9/5/25 |